CTRI/2020/03/023879CompletedPhase 3
Efficacy of Virechana Karma and Kaala Basti in the Management of Pakshaghata: An Open Labelled Randomized Comparative Clinical Trial.
IPGT and RA0 sites22 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Enrollment
- 22
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •(1) Patient having signs and symptoms of
- •Pakshaghata fulfilling diagnostic criteria.
- •(2) Patients who are Yogya for Virechana Karma
- •and Basti Karma.
- •(3) Mild to moderate hypertensive shall be
- •considered. (Antihypertensive,
- •Anticoagulant, Antidiabetic Medicines will
- •be continued.)
- •(4) Chronicity limits upto 1 year
Exclusion Criteria
- •(1)Patients who are Ayogya for Virechana Karma
- •and Basti Karma.
- •(2)Uncontrol hypertension.
- •(3)Patients of Intracranial infection.
- •(4)Degenerative lesions.
- •(5)Intracranial space occupying lesions and
- •(6)Patients with altered sensorium
- •(7)Chronicity limits more than 1year.
Investigators
Similar Trials
Not yet recruiting
Phase 2
Effect Of Purgation And Enema On Anovulation Factor In InfertilityCTRI/2024/05/067693ational Institute Of Ayurveda Jaipur
Not yet recruiting
Phase 3
Effect of Virechana, basti and Taila pana in the treatment of Paralysis(Hemiplegia)CTRI/2018/01/011406Institute For Post Graduate Training And Research In Ayurveda
Completed
Phase 3
Comparision between Vamana Karma and Virechana Karma in Shwitra or Vitiligo.CTRI/2020/03/023750IPGT and RA22
Not yet recruiting
Phase 4
Effect of Purgation therapy and Patoladhanayakadi decoction in the management of HyperacidityCTRI/2019/04/018747Ipgt and ra
Not yet recruiting
Phase 3
Effect of Vamana Virechana and Pippalikhanda in Amlapitta or HyperacidityCTRI/2017/12/010915Institute for Post Graduate Training And Research Centre